Abstract:Dendritic cells (DCs) have been intensively studied in correlation to tumor immunology and for the development DC-based cancer vaccines. Here, we present the significance of the temporal aspect of DC maturation for the most essential subsequent timepoint, namely at interaction with responding T cells or after CD40-Ligand restimulation. Mostly, DC maturation is still being achieved by activation processes which lasts 24 h to 48 h. We hypothesized this amount of time is excessive from a biological standpoint and could be the underlying cause for functional exhaustion. Indeed, shorter maturation periods resulted in extensive capacity of monocyte-derived DCs to produce inflammatory cytokines after re-stimulation with CD40-Ligand. This effect was most evident for the primary type 1 polarizing cytokine, IL-12p70. This capacity reached peak at 6 h and dropped sharply with longer exposure to initial maturation stimuli (up to 48 h). The 6 h maturation protocol reflected superiority in subsequent functionality tests. Namely, DCs displayed twice the allostimulatory capacity of 24 h- and 48 h-matured DCs. Similarly, type 1 T cell response measured by IFN-γ production was 3-fold higher when CD4 + T cells had been stimulated with shortly matured DC and over 8-fold greater in case of CD8 + T cells, compared to longer matured DCs. The extent of melanoma-specific CD8 + cytotoxic T cell induction was also greater in case of 6 h DC maturation. The major limitation of the study is that it lacks in vivo evidence, which we aim to examine in the future. Our findings show an unexpectedly significant impact of temporal exposure to activation signals for subsequent DC functionality, which we believe can be readily integrated into existing knowledge on in vitro/ex vivo DC manipulation for various uses. We also believe this has important implications for DC vaccine design for future clinical trials.

Differential activation profiles of multiple transcription factors during dendritic cell maturation.

Transcription factor E2F1 suppresses dendritic cell maturation.

Transcriptional Profiles During the Differentiation and Maturation of Monocyte-Derived Dendritic Cells, Analyzed Using Focused Microarrays.

Transcription factor E2F1 suppresses dendritic cell maturation. (167.3)

Transcriptional regulation of dendritic cell development and function

Transcriptional Programming of Dendritic Cells for Enhanced MHC Class II Antigen Presentation

Transcriptional control of dendritic cell development and functions

Transcriptional Networks Driving Dendritic Cell Differentiation and Function

JAK/STAT signaling pathway in the process of differentiation and maturation of Dendritic calls

Dendritic Cell Maturation in the Tumor Microenvironment

The Network of Cytokines, Receptors and Transcription Factors Governing the Development of Dendritic Cell Subsets

Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity

Differential Induction of Interleukin-10 and Interleukin-12 in Dendritic Cells by Microbial Toll-Like Receptor Activators and Skewing of T-Cell Cytokine Profiles

Differential Expression Regulation of the Alpha and Beta Subunits of the PA28 Proteasome Activator in Mature Dendritic Cells.

Dendritic Cells—A Conductor of T Cell Differentiation—

Distinct functional capacities of mouse thymic and splenic dendritic cell populations

Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies

The Character of Differentiation and Maturity of Cultured Human Dendritic Cells

Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses

Factor of time in dendritic cell (DC) maturation: short-term activation of DCs significantly improves type 1 cytokine production and T cell responses

Novel Insights into the Relationships Between Dendritic Cell Subsets in Human and Mouse Revealed by Genome-Wide Expression Profiling